Zhang, W., Bai, F., Wang, J., Zheng, R., Yang, L., James, E. A., & Zhao, Z. (2017). Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor. Drug Des Devel Ther.

Zhang, Wei-Wei, Feng Bai, Jin Wang, Rong-Hua Zheng, Li-Wang Yang, Erskine A. James, και Zhi-Qing Zhao. "Edaravone Inhibits Pressure Overload-induced Cardiac Fibrosis and Dysfunction By Reducing Expression of Angiotensin II AT1 Receptor." Drug Des Devel Ther 2017.

Zhang, Wei-Wei, et al. "Edaravone Inhibits Pressure Overload-induced Cardiac Fibrosis and Dysfunction By Reducing Expression of Angiotensin II AT1 Receptor." Drug Des Devel Ther 2017.